{"title": "Infecciones por coronavirus", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2022-06-17", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "vacunas\n[Dem\u00f3cratas piden a Biden eliminar m\u00e1s sanciones para facilitar distribuci\u00f3n mundial de vacunas anticovid cubanas](https://temas.sld.cu/coronavirus/2022/06/16/democratas-piden-a-biden-eliminar-mas-sanciones-para-facilitar-distribucion-mundial-de-vacunas-anticovid-cubanas/)\n[Experta en derechos humanos pide acabar con la situaci\u00f3n de apartheid de las vacunas contra el COVID-19](https://temas.sld.cu/coronavirus/2022/06/15/experta-en-derechos-humanos-pide-acabar-con-la-situacion-de-apartheid-de-las-vacunas-contra-el-covid-19/)\nInvestigadores cubanos recibieron el Premio Anual de Inmunolog\u00eda Jorge Gavilondo Cowley in Memoriam por el trabajo investigativo \u201cDise\u00f1o, desarrollo y evaluaci\u00f3n precl\u00ednica de Soberana 02: una vacuna cubana contra la COVID-19\u201d, inform\u00f3 en su cuenta en Twitter el Instituto Finlay de Vacunas (IFV).\n[Ver m\u00e1s\u2026](https://temas.sld.cu/coronavirus/2022/06/14/entregan-premio-anual-de-inmunologia-a-trabajo-investigativo-sobre-la-vacuna-anticovid-soberana-02/#more-18502)\n[Publica revista de alto impacto \u00abThe Lancet Respiratory Medicine\u00bb resultados de ensayos cl\u00ednicos fase II de Soberana Plus](https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/)\nLa prestigiosa revista The Lancet Respiratory Medicine public\u00f3 el 9 de junio\n[un informe](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00100-X/fulltext) con los resultados de los ensayos cl\u00ednicos Fase 2a y 2b de la vacuna cubana anticovid Soberana Plus. [Ver m\u00e1s\u2026](https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/#more-18474)\nLa inauguraci\u00f3n, en Ir\u00e1n, de una planta de producci\u00f3n de la vacuna anti-COVID-19 denominada PastoCorona \u2013resultado de la transferencia de tecnolog\u00eda de Soberana 02, del Instituto Finlay de Vacunas (IFV), al Instituto Pasteur\u2013, convierte al pa\u00eds persa en el primero en fabricar industrialmente uno de los inmun\u00f3genos cubanos contra el SARS-COV-2, resalt\u00f3 en\n[Ver m\u00e1s\u2026](https://temas.sld.cu/coronavirus/2022/05/16/iran-sera-la-primera-nacion-en-producir-una-de-las-vacunas-cubanas-contra-la-covid-19/#more-18241)\n[Cinco factores que explican la diferencia de lo que ha ocurrido en Cuba con la llegada de \u00d3micron respecto al mundo](https://temas.sld.cu/coronavirus/2022/04/19/cinco-factores-que-explican-la-diferencia-de-lo-que-ha-ocurrido-en-cuba-con-la-llegada-de-omicron-respecto-al-mundo/)\nLos resultados precl\u00ednicos de un candidato vacunal anti-COVID-19 que emplea un liposoma recubierto con oligonucle\u00f3tidos con efecto agonista sobre el\n[receptor tipo Toll 9](https://www.ncbi.nlm.nih.gov/gene/54106), sugieren la importancia los elementos estructurales y de presentaci\u00f3n antig\u00e9nica para la inmunogenicidad. [Ver m\u00e1s\u2026](https://temas.sld.cu/coronavirus/2022/04/14/plataforma-vacunal-basada-en-acidos-nucleicos-esfericos/#more-18042)\nLa direcci\u00f3n del pa\u00eds y las autoridades sanitarias consensuaron la conveniencia de aplicar la primera dosis de refuerzo con las vacunas cubanas anti-COVID-19, a adolescentes y j\u00f3venes en las edades comprendidas entre los 12 y 18 a\u00f1os de edad que hayan cumplido seis meses del esquema completo de la primo-vacunaci\u00f3n.\n[Ver m\u00e1s\u2026](https://temas.sld.cu/coronavirus/2022/04/13/habra-dosis-de-refuerzo-para-adolescentes-y-jovenes-entre-los-12-y-los-18-anos-de-edad/#more-18037)\nEl prestigioso grupo brit\u00e1nico The Lancet Discovery Science public\u00f3 en su revista\n[eClinicalMedicine](https://www.thelancet.com/journals/eclinm/home) un art\u00edculo cient\u00edfico sobre la vacuna Abdala, donde evidencia que es segura, bien tolerada e induce una potente respuesta inmune contra el SARS-CoV-2. [Ver m\u00e1s\u2026](https://temas.sld.cu/coronavirus/2022/04/13/revista-britanica-del-grupo-the-lancet-publica-articulo-cientifico-sobre-vacuna-cubana-abdala/#more-18026)", "language": null, "image": null, "pagetype": null, "links": ["http://www.sld.cu", "http://www.sld.cu/red-de-portales", "http://www.uvs.sld.cu", "http://www.bvs.sld.cu", "http://temas.sld.cu/coronavirus/", "http://temas.sld.cu/coronavirus/", "https://temas.sld.cu/coronavirus/acerca-de/", "https://temas.sld.cu/coronavirus/recursos-de-informacion/", "https://temas.sld.cu/coronavirus/presentaciones/", "https://temas.sld.cu/coronavirus/preguntas-al-especialista/", "https://temas.sld.cu/coronavirus/2022/06/17/proteccion-y-disminucion-de-la-inmunidad-natural-e-hibrida-al-sars-cov-2/", "https://temas.sld.cu/coronavirus/2022/06/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/propuestas-del-editor/revisiones-y-metanalisis/", "https://temas.sld.cu/coronavirus/2022/06/17/proteccion-y-disminucion-de-la-inmunidad-natural-e-hibrida-al-sars-cov-2/#respond", "https://temas.sld.cu/coronavirus/2022/06/17/proteccion-y-disminucion-de-la-inmunidad-natural-e-hibrida-al-sars-cov-2/", "https://temas.sld.cu/coronavirus/2022/06/17/proteccion-y-disminucion-de-la-inmunidad-natural-e-hibrida-al-sars-cov-2/#respond", "https://temas.sld.cu/coronavirus/2022/06/17/proteccion-y-disminucion-de-la-inmunidad-natural-e-hibrida-al-sars-cov-2/#more-18516", "https://temas.sld.cu/coronavirus/2022/06/16/democratas-piden-a-biden-eliminar-mas-sanciones-para-facilitar-distribucion-mundial-de-vacunas-anticovid-cubanas/", "https://temas.sld.cu/coronavirus/2022/06/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/actualidades/terapeutica/", "https://temas.sld.cu/coronavirus/2022/06/16/democratas-piden-a-biden-eliminar-mas-sanciones-para-facilitar-distribucion-mundial-de-vacunas-anticovid-cubanas/#respond", "https://temas.sld.cu/coronavirus/2022/06/16/democratas-piden-a-biden-eliminar-mas-sanciones-para-facilitar-distribucion-mundial-de-vacunas-anticovid-cubanas/", "https://temas.sld.cu/coronavirus/2022/06/16/democratas-piden-a-biden-eliminar-mas-sanciones-para-facilitar-distribucion-mundial-de-vacunas-anticovid-cubanas/#respond", "https://temas.sld.cu/coronavirus/2022/06/16/democratas-piden-a-biden-eliminar-mas-sanciones-para-facilitar-distribucion-mundial-de-vacunas-anticovid-cubanas/#more-18529", "https://temas.sld.cu/coronavirus/2022/06/15/experta-en-derechos-humanos-pide-acabar-con-la-situacion-de-apartheid-de-las-vacunas-contra-el-covid-19/", "https://temas.sld.cu/coronavirus/2022/06/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/actualidades/terapeutica/", "https://temas.sld.cu/coronavirus/2022/06/15/experta-en-derechos-humanos-pide-acabar-con-la-situacion-de-apartheid-de-las-vacunas-contra-el-covid-19/#respond", "https://temas.sld.cu/coronavirus/2022/06/15/experta-en-derechos-humanos-pide-acabar-con-la-situacion-de-apartheid-de-las-vacunas-contra-el-covid-19/", "https://temas.sld.cu/coronavirus/2022/06/15/experta-en-derechos-humanos-pide-acabar-con-la-situacion-de-apartheid-de-las-vacunas-contra-el-covid-19/#respond", "https://temas.sld.cu/coronavirus/2022/06/15/experta-en-derechos-humanos-pide-acabar-con-la-situacion-de-apartheid-de-las-vacunas-contra-el-covid-19/#more-18507", "https://temas.sld.cu/coronavirus/2022/06/14/entregan-premio-anual-de-inmunologia-a-trabajo-investigativo-sobre-la-vacuna-anticovid-soberana-02/", "https://temas.sld.cu/coronavirus/2022/06/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/actualidades/terapeutica/", "https://temas.sld.cu/coronavirus/2022/06/14/entregan-premio-anual-de-inmunologia-a-trabajo-investigativo-sobre-la-vacuna-anticovid-soberana-02/#respond", "https://temas.sld.cu/coronavirus/2022/06/14/entregan-premio-anual-de-inmunologia-a-trabajo-investigativo-sobre-la-vacuna-anticovid-soberana-02/", "https://temas.sld.cu/coronavirus/2022/06/14/entregan-premio-anual-de-inmunologia-a-trabajo-investigativo-sobre-la-vacuna-anticovid-soberana-02/#respond", "https://temas.sld.cu/coronavirus/2022/06/14/entregan-premio-anual-de-inmunologia-a-trabajo-investigativo-sobre-la-vacuna-anticovid-soberana-02/#more-18502", "https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/", "https://temas.sld.cu/coronavirus/2022/06/", "https://temas.sld.cu/coronavirus/category/propuestas-del-editor/autores-cubanos/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/#respond", "https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/", "https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/#respond", "https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00100-X/fulltext", "https://temas.sld.cu/coronavirus/2022/06/13/publica-revista-de-alto-impacto-the-lancet-respiratory-medicine-resultados-de-ensayos-clinicos-fase-ii-de-soberana-plus/#more-18474", "https://temas.sld.cu/coronavirus/2022/05/16/iran-sera-la-primera-nacion-en-producir-una-de-las-vacunas-cubanas-contra-la-covid-19/", "https://temas.sld.cu/coronavirus/2022/05/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/actualidades/terapeutica/", "https://temas.sld.cu/coronavirus/2022/05/16/iran-sera-la-primera-nacion-en-producir-una-de-las-vacunas-cubanas-contra-la-covid-19/#respond", "https://temas.sld.cu/coronavirus/2022/05/16/iran-sera-la-primera-nacion-en-producir-una-de-las-vacunas-cubanas-contra-la-covid-19/", "https://temas.sld.cu/coronavirus/2022/05/16/iran-sera-la-primera-nacion-en-producir-una-de-las-vacunas-cubanas-contra-la-covid-19/#respond", "https://twitter.com/FinlayInstituto/status/1525882182950076416?ref_src=twsrc%5Etfw", "https://temas.sld.cu/coronavirus/2022/05/16/iran-sera-la-primera-nacion-en-producir-una-de-las-vacunas-cubanas-contra-la-covid-19/#more-18241", "https://temas.sld.cu/coronavirus/2022/04/19/cinco-factores-que-explican-la-diferencia-de-lo-que-ha-ocurrido-en-cuba-con-la-llegada-de-omicron-respecto-al-mundo/", "https://temas.sld.cu/coronavirus/2022/04/", "https://temas.sld.cu/coronavirus/category/actualidades/comportamiento-y-evolucion-del-virus/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/2022/04/19/cinco-factores-que-explican-la-diferencia-de-lo-que-ha-ocurrido-en-cuba-con-la-llegada-de-omicron-respecto-al-mundo/#respond", "https://temas.sld.cu/coronavirus/2022/04/19/cinco-factores-que-explican-la-diferencia-de-lo-que-ha-ocurrido-en-cuba-con-la-llegada-de-omicron-respecto-al-mundo/", "https://temas.sld.cu/coronavirus/2022/04/19/cinco-factores-que-explican-la-diferencia-de-lo-que-ha-ocurrido-en-cuba-con-la-llegada-de-omicron-respecto-al-mundo/#respond", "https://temas.sld.cu/coronavirus/2022/04/19/cinco-factores-que-explican-la-diferencia-de-lo-que-ha-ocurrido-en-cuba-con-la-llegada-de-omicron-respecto-al-mundo/#more-18084", "https://temas.sld.cu/coronavirus/2022/04/14/plataforma-vacunal-basada-en-acidos-nucleicos-esfericos/", "https://temas.sld.cu/coronavirus/2022/04/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/propuestas-del-editor/", "https://temas.sld.cu/coronavirus/2022/04/14/plataforma-vacunal-basada-en-acidos-nucleicos-esfericos/#respond", "https://temas.sld.cu/coronavirus/2022/04/14/plataforma-vacunal-basada-en-acidos-nucleicos-esfericos/", "https://temas.sld.cu/coronavirus/2022/04/14/plataforma-vacunal-basada-en-acidos-nucleicos-esfericos/#respond", "https://www.ncbi.nlm.nih.gov/gene/54106", "https://temas.sld.cu/coronavirus/2022/04/14/plataforma-vacunal-basada-en-acidos-nucleicos-esfericos/#more-18042", "https://temas.sld.cu/coronavirus/2022/04/13/habra-dosis-de-refuerzo-para-adolescentes-y-jovenes-entre-los-12-y-los-18-anos-de-edad/", "https://temas.sld.cu/coronavirus/2022/04/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/actualidades/terapeutica/", "https://temas.sld.cu/coronavirus/2022/04/13/habra-dosis-de-refuerzo-para-adolescentes-y-jovenes-entre-los-12-y-los-18-anos-de-edad/#respond", "https://temas.sld.cu/coronavirus/2022/04/13/habra-dosis-de-refuerzo-para-adolescentes-y-jovenes-entre-los-12-y-los-18-anos-de-edad/", "https://temas.sld.cu/coronavirus/2022/04/13/habra-dosis-de-refuerzo-para-adolescentes-y-jovenes-entre-los-12-y-los-18-anos-de-edad/#respond", "https://temas.sld.cu/coronavirus/2022/04/13/habra-dosis-de-refuerzo-para-adolescentes-y-jovenes-entre-los-12-y-los-18-anos-de-edad/#more-18037", "https://temas.sld.cu/coronavirus/2022/04/13/revista-britanica-del-grupo-the-lancet-publica-articulo-cientifico-sobre-vacuna-cubana-abdala/", "https://temas.sld.cu/coronavirus/2022/04/", "https://temas.sld.cu/coronavirus/category/temas/covid-19/", "https://temas.sld.cu/coronavirus/category/propuestas-del-editor/", "https://temas.sld.cu/coronavirus/2022/04/13/revista-britanica-del-grupo-the-lancet-publica-articulo-cientifico-sobre-vacuna-cubana-abdala/#respond", "https://temas.sld.cu/coronavirus/2022/04/13/revista-britanica-del-grupo-the-lancet-publica-articulo-cientifico-sobre-vacuna-cubana-abdala/", "https://temas.sld.cu/coronavirus/2022/04/13/revista-britanica-del-grupo-the-lancet-publica-articulo-cientifico-sobre-vacuna-cubana-abdala/#respond", "https://www.thelancet.com/journals/eclinm/home", "https://temas.sld.cu/coronavirus/2022/04/13/revista-britanica-del-grupo-the-lancet-publica-articulo-cientifico-sobre-vacuna-cubana-abdala/#more-18026", "https://temas.sld.cu/coronavirus/tag/vacunas/page/3/", "https://temas.sld.cu/coronavirus/tag/vacunas/", "https://temas.sld.cu/coronavirus/tag/vacunas/page/2/", "https://temas.sld.cu/coronavirus/tag/vacunas/page/3/", "https://temas.sld.cu/coronavirus/tag/vacunas/page/5/", "https://temas.sld.cu/coronavirus/tag/vacunas/page/6/", "https://temas.sld.cu/coronavirus/tag/vacunas/page/7/", "https://temas.sld.cu/coronavirus/tag/vacunas/page/5/", "https://temas.sld.cu/coronavirus/acerca-de/", "http://interactivos.cubadebate.cu/", "https://temas.sld.cu/coronavirus/2022/02/14/disponible-a-partir-de-hoy-certificado-digital-de-vacunacion-de-cuba/", "https://temas.sld.cu/coronavirus/covid-19/minsap-estrategia-e-indicaciones/", "https://temas.sld.cu/coronavirus/covid-19/", "https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports", "https://temas.sld.cu/coronavirus/mers/", "https://temas.sld.cu/coronavirus/coronavirus/", "http://temas.sld.cu/coronavirus/feed/", "http://temas.sld.cu/coronavirus/contacto/", "http://temas.sld.cu/coronavirus/mapa-del-sitio/", "http://temas.sld.cu/coronavirus/busqueda-avanzada/", "https://temas.sld.cu/coronavirus/coronavirus/", "https://temas.sld.cu/coronavirus/coronavirus/medidas-preventivas/", "https://temas.sld.cu/coronavirus/covid-19/", "https://temas.sld.cu/coronavirus/mers/", "https://temas.sld.cu/coronavirus/sars-cov/", "https://boletinaldia.sld.cu/aldia/category/enfermedades/sars/", "https://espanol.cdc.gov/coronavirus/2019-ncov/index.html", "https://fundeu.es/coronavirus-recomendaciones-lenguaje/", "https://www.intramed.net/contenidolista.asp?contenidotipoid=51", "https://medlineplus.gov/spanish/ency/article/007767.htm", "https://www.medscape.com/resource/coronavirus", "https://news.un.org/es/search/coronavirus", "https://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?query=Coronavirus&v%3Aproject=nlm-main-website", "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=Betacoronavirus,%20taxid:694002", "https://www.niaid.nih.gov/diseases-conditions/mers-and-sars", "https://www.who.int/health-topics/coronavirus", "https://www.paho.org/es/temas/coronavirus", "https://www.tremedica.org/area-de-socios/glosarios/glosario-de-covid-19-en-es/", "https://www.viprbrc.org/brc/home.spg?decorator=corona", "http://especialidades.sld.cu/higienepidemiologia/", "http://temas.sld.cu/influenza/", "http://instituciones.sld.cu/ipk/departamento-virologia/", "http://instituciones.sld.cu/inhem/", "https://salud.msp.gob.cu/", "http://instituciones.sld.cu/upp/", "http://temas.sld.cu/vigilanciaensalud", "https://temas.sld.cu/vigilanciaensalud/consejos-que-todo-viajero-debe-conocer/", "http://infomed20.sld.cu/infoenlaces/tags.php/coronavirus", "http://infomed20.sld.cu/infoenlaces/search.php/all/covid", "http://infomed20.sld.cu/infoenlaces/tags.php/mers", "http://infomed20.sld.cu/infoenlaces/tags.php/sars", "http://infomed20.sld.cu/infoenlaces/tags.php/sras", "https://temas.sld.cu/coronavirus/los-lectores-comentan/", "https://pubmed.ncbi.nlm.nih.gov/rss/search/1lqZ3NPYyseAVIusxx80mASGu3sAGL9W1fSsK0rfEum9M00k9F/?limit=15&utm_campaign=pubmed-2&fc=20230711143254", "https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1lqZ3NPYyseAVIusxx80mASGu3sAGL9W1fSsK0rfEum9M00k9F&utm_campaign=pubmed-2&fc=20230711143254&utm_content=1lqZ3NPYyseAVIusxx80mASGu3sAGL9W1fSsK0rfEum9M00k9F&v=2.17.9.post6+86293ac&utm_source=WordPress&utm_medium=rss&ff=20230920121917", "https://pubmed.ncbi.nlm.nih.gov/37727750/?utm_source=WordPress&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1lqZ3NPYyseAVIusxx80mASGu3sAGL9W1fSsK0rfEum9M00k9F&fc=20230711143254&ff=20230920121917&v=2.17.9.post6+86293ac", "http://ftp.sld.cu/pub/APK_Salud/covid19infocu.apk", "http://ftp.sld.cu/pub/APK_Salud/covid19infocu.apk", "https://www.apklis.cu/application/cu.sld.COVID_19_InfoCU", "https://temas.sld.cu/coronavirus/2023/08/09/galeria-de-imagenes-sobre-covid-19-para-la-ciencia-y-los-medios/", "https://www.amprogress.org/covid-19-resources/covid-19-photo-library/", "https://temas.sld.cu/coronavirus/category/imagenes/", "https://www.paho.org/hq/index.php?option=com_content&view=article&id=1239:epidemiological-alerts-updates&Itemid=2291&lang=en", "https://www.who.int/emergencies/diseases/en/", "http://www.healthmap.org/es/", "https://medisys.newsbrief.eu/medisys/alertedition/en/CoronavirusInfection.html", "https://medisys.newsbrief.eu/emmMap/?type=category&language=all&category=CoronavirusInfection", "https://promedmail.org/coronavirus/", "https://www.who.int/wer/en/", "https://covid19.who.int/", "https://temas.sld.cu/coronavirus/presentaciones/actividades-de-postgrado-el-instituto-de-medicina-tropical-pedro-kouri/", "https://www.campusvirtualsp.org/es/courses/self-learning?field_nombre_del_curso_value=covid&field_sol_cursos_categoria_tid=All", "http://directoriocursos.sld.cu/index.php?P=BrowseResources&ID=734", "http://www.cencomed.sld.cu/navegar-por-eventos?icw_bid=6&icw_voc_id=86&icw_velem=751", "https://temas.sld.cu/coronavirus/eventos-reuniones-y-congresos-cientificos/", "https://www.revolvermaps.com/livestats/0tgyy5cih66/", "https://www.revolvermaps.com/livestats/0tgyy5cih66/", "https://temas.sld.cu/coronavirus/tag/america/", "https://temas.sld.cu/coronavirus/tag/america-latina/", "https://temas.sld.cu/coronavirus/tag/animales/", "https://temas.sld.cu/coronavirus/tag/arabia-saudita/", "https://temas.sld.cu/coronavirus/tag/china/", "https://temas.sld.cu/coronavirus/tag/comorbilidades/", "https://temas.sld.cu/coronavirus/tag/comunicacion/", "https://temas.sld.cu/coronavirus/tag/cuba/", "https://temas.sld.cu/coronavirus/tag/ensayos-clinicos/", "https://temas.sld.cu/coronavirus/tag/epidemia/", "https://temas.sld.cu/coronavirus/tag/estado-grave/", "https://temas.sld.cu/coronavirus/tag/estados-unidos/", "https://temas.sld.cu/coronavirus/tag/estadisticas/", "https://temas.sld.cu/coronavirus/tag/estrategias/", "https://temas.sld.cu/coronavirus/tag/estudios-genomicos/", "https://temas.sld.cu/coronavirus/tag/factores-de-riesgo/", "https://temas.sld.cu/coronavirus/tag/fase-de-recuperacion/", "https://temas.sld.cu/coronavirus/tag/impacto-psicologico/", "https://temas.sld.cu/coronavirus/tag/impacto-social/", "https://temas.sld.cu/coronavirus/tag/instituciones/", "https://temas.sld.cu/coronavirus/tag/investigacion-cientifica/", "https://temas.sld.cu/coronavirus/tag/la-habana/", "https://temas.sld.cu/coronavirus/tag/medicamentos/", "https://temas.sld.cu/coronavirus/tag/minsap/", "https://temas.sld.cu/coronavirus/tag/mortalidad/", "https://temas.sld.cu/coronavirus/tag/mujer-embarazada/", "https://temas.sld.cu/coronavirus/tag/mutaciones/", "https://temas.sld.cu/coronavirus/tag/ninos/", "https://temas.sld.cu/coronavirus/tag/oms/", "https://temas.sld.cu/coronavirus/tag/ops/", "https://temas.sld.cu/coronavirus/tag/pandemia/", "https://temas.sld.cu/coronavirus/tag/prevencion/", "https://temas.sld.cu/coronavirus/tag/protocolos/", "https://temas.sld.cu/coronavirus/tag/publicaciones/", "https://temas.sld.cu/coronavirus/tag/respuesta-inmunitaria/", "https://temas.sld.cu/coronavirus/tag/secuelas/", "https://temas.sld.cu/coronavirus/tag/servicios-de-salud/", "https://temas.sld.cu/coronavirus/tag/situacion-epidemiologica/", "https://temas.sld.cu/coronavirus/tag/sintomas/", "https://temas.sld.cu/coronavirus/tag/trabajadores-de-la-salud/", "https://temas.sld.cu/coronavirus/tag/transmisibilidad/", "https://temas.sld.cu/coronavirus/tag/transmision-autoctona-limitada/", "https://temas.sld.cu/coronavirus/tag/vacunacion/", "https://temas.sld.cu/coronavirus/tag/vacunas/", "https://temas.sld.cu/coronavirus/tag/variantes/", "http://documentosevaluativos.sld.cu/index.php?P=AdvancedSearch&Q=Y&FK=coronavirus&RP=10&SR=0&ST=Quick", "https://temas.sld.cu/coronavirus/", "https://temas.sld.cu/coronavirus/contacto/", "https://webmail.sld.cu/", "http://documentosevaluativos.sld.cu/index.php?P=AdvancedSearch&Q=Y&FK=coronavirus&RP=10&SR=0&ST=Quick", "http://temas.sld.cu/coronavirus/contacto", "http://www.sld.cu/pagina/2014/03/25/politicas-del-portal-de-infomed", "http://www.sld.cu/", "http://www.semiologic.com/software/sem-reloaded/", "http://skins.semiologic.com/boxed/", "http://www.mesoconcepts.com"]}